PortfoliosLab logoPortfoliosLab logo
BNGO vs. CLF
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

BNGO vs. CLF - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Bionano Genomics, Inc. (BNGO) and Cleveland-Cliffs Inc. (CLF). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, BNGO achieves a -23.53% return, which is significantly higher than CLF's -26.88% return.


BNGO

1D
-2.50%
1M
0.86%
6M
-26.42%
YTD
-23.53%
1Y
-65.59%
3Y*
-85.56%
5Y*
-79.75%
10Y*

CLF

1D
3.30%
1M
-29.54%
6M
-24.79%
YTD
-26.88%
1Y
-1.62%
3Y*
-16.64%
5Y*
-14.97%
10Y*
3.46%
*Multi-year figures are annualized to reflect compound growth (CAGR)

BNGO vs. CLF - Yearly Performance Comparison


2026 (YTD)20252024202320222021202020192018
BNGO
Bionano Genomics, Inc.
-23.53%-91.16%-84.74%-87.05%-51.17%-2.92%148.39%-76.34%-47.60%
CLF
Cleveland-Cliffs Inc.
-26.88%41.28%-53.97%26.75%-26.00%49.52%77.38%12.72%-37.07%

Correlation

The correlation between BNGO and CLF is 0.22, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.22

Correlation (3Y)
Calculated over the trailing 3-year period

0.25

Correlation (5Y)
Calculated over the trailing 5-year period

0.32

Correlation (All Time)
Calculated using the full available price history since Sep 21, 2018

0.23

Fundamentals

Market Cap

BNGO:

$13.43M

CLF:

$5.54B

EPS

BNGO:

-$6.48

CLF:

-$2.35

PS Ratio

BNGO:

0.19

CLF:

0.27

Total Revenue (TTM)

BNGO:

$22.06M

CLF:

$18.90B

Gross Profit (TTM)

BNGO:

$3.32M

CLF:

-$528.00M

EBITDA (TTM)

BNGO:

-$23.09M

CLF:

$134.00M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

BNGO vs. CLF — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

BNGO
BNGO Risk / Return Rank: 1212
Overall Rank
BNGO Sharpe Ratio Rank: 1010
Sharpe Ratio Rank
BNGO Sortino Ratio Rank: 1111
Sortino Ratio Rank
BNGO Omega Ratio Rank: 88
Omega Ratio Rank
BNGO Calmar Ratio Rank: 1010
Calmar Ratio Rank
BNGO Martin Ratio Rank: 2323
Martin Ratio Rank

CLF
CLF Risk / Return Rank: 4545
Overall Rank
CLF Sharpe Ratio Rank: 4444
Sharpe Ratio Rank
CLF Sortino Ratio Rank: 4646
Sortino Ratio Rank
CLF Omega Ratio Rank: 4545
Omega Ratio Rank
CLF Calmar Ratio Rank: 4444
Calmar Ratio Rank
CLF Martin Ratio Rank: 4444
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

BNGO vs. CLF - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Bionano Genomics, Inc. (BNGO) and Cleveland-Cliffs Inc. (CLF). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


BNGOCLFDifference
Sharpe ratioReturn per unit of total volatility

-0.79

Sortino ratioReturn per unit of downside risk

-1.57

Omega ratioGain probability vs. loss probability

0.83

1.06

-0.23

Calmar ratioReturn relative to maximum drawdown

-0.84

-0.03

-0.81

Martin ratioReturn relative to average drawdown

-1.01

-0.06

-0.95

BNGO vs. CLF - Sharpe Ratio Comparison

The current BNGO Sharpe Ratio is -0.81, which is lower than the CLF Sharpe Ratio of -0.02. The chart below compares the historical Sharpe Ratios of BNGO and CLF, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

BNGO vs. CLF - Drawdown Comparison

The maximum BNGO drawdown since its inception was -99.99%, roughly equal to the maximum CLF drawdown of -98.78%. Use the drawdown chart below to compare losses from any high point for BNGO and CLF.


Loading charts...

Drawdown Indicators


BNGOCLFDifference

Max Drawdown

Largest peak-to-trough decline

-99.99%

-98.78%

-1.21%

Max Drawdown (1Y)

Largest decline over 1 year

-77.85%

-51.67%

-26.18%

Max Drawdown (3Y)

Largest decline over 3 years

-99.72%

-74.46%

-25.26%

Max Drawdown (5Y)

Largest decline over 5 years

-99.97%

-82.37%

-17.60%

Max Drawdown (10Y)

Largest decline over 10 years

-82.37%

Current Drawdown

Current decline from peak

-99.99%

-90.10%

-9.89%

Average Drawdown

Average peak-to-trough decline

-85.37%

-47.71%

-37.66%

Ulcer Index

Depth and duration of drawdowns from previous peaks

64.76%

26.86%

+37.90%

Volatility

BNGO vs. CLF - Volatility Comparison

The current volatility for Bionano Genomics, Inc. (BNGO) is 10.11%, while Cleveland-Cliffs Inc. (CLF) has a volatility of 18.58%. This indicates that BNGO experiences smaller price fluctuations and is considered to be less risky than CLF based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


BNGOCLFDifference

Volatility (1M)

Calculated over the trailing 1-month period

10.11%

18.58%

-8.47%

Volatility (6M)

Calculated over the trailing 6-month period

45.36%

47.89%

-2.53%

Volatility (1Y)

Calculated over the trailing 1-year period

81.33%

67.77%

+13.56%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

89.69%

59.19%

+30.50%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

190.70%

61.94%

+128.76%

Dividends

BNGO vs. CLF - Dividend Comparison

Neither BNGO nor CLF has paid dividends to shareholders.


PositionTTM2025202420232022202120202019
BNGO
Bionano Genomics, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
CLF
Cleveland-Cliffs Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.82%3.10%

Financials

BNGO vs. CLF - Financials Comparison

This section allows you to compare key financial metrics between Bionano Genomics, Inc. and Cleveland-Cliffs Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.001.00B2.00B3.00B4.00B5.00B6.00BJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025AprilJulyOctober2026
6.69K
4.92B
(BNGO) Total Revenue
(CLF) Total Revenue
Values in USD except per share items

Frequently Asked Questions


BNGO and CLF have a correlation of 0.22, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

CLF has higher volatility (18.58%) compared to BNGO (10.11%). In terms of maximum drawdown, BNGO dropped -99.99% vs CLF's -98.78%.

CLF currently has the higher Sharpe Ratio (-0.02 vs -0.81), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for BNGO and CLF

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer